NCT07431489
- Conditions
- MEK Inhibitor-Associated Retinopathy, Malignant Melanoma, Melanoma, +11 more
- Locations
-
- Institute of Oncology Ljubljana Ljubljana, Slovenia
Clinical trial condition
Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.
NCT07431489
NCT07428954
NCT03400332
NCT07428941
NCT02669173
NCT05984667
NCT01659151
NCT05938387
NCT07416838
NCT03343197